Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 50
Filtrar
1.
Otol Neurotol ; 40(8): e787-e795, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31415481

RESUMO

OBJECTIVE: To evaluate the hearing outcomes of cochlear implantation in different age groups by using data collected in the HEARRING registry. METHODS: A multicenter study. Data of 146 patients were collected in a HEARRING registry. Patients were divided into three different age groups; ≤ 55 years old (age group 1, n = 66), 56 to 69 years old (age group 2, n = 45), and ≥ 70 years old (age group 3, n = 35). Speech in quiet (SPIQ), speech in noise (SPIN), and hearing implant sound quality index (HISQUI19) scores were evaluated for the different age groups at different test moments (preoperatively, 3, 6, 12, and 24 mo after first fitting). RESULTS: A statistically significant difference (p < 0.01) was found between preoperative scores and the scores on all the follow-up moments across all age groups. For SPIQ and SPIN, none of the time points showed a statistically significant age effect (p = 0.88 and p = 0.89). For HISQUI19 scores, a statistically significant age effect was found at 12 months after first fitting. The oldest age group scored significantly lower on the HISQUI19 compared with the youngest age group. CONCLUSION: Hearing outcomes of adult cochlear implant users of different age groups were evaluated. The SPIQ and SPIN tests showed no significant differences between the different age groups. Nevertheless, the youngest group scored significantly better on self -perceived benefit (HISQUI19) with a cochlear implant compared with the oldest age group.Further research is needed to receive more insight into cochlear implantation in the elderly and its implications on rehabilitating and supporting this expanding older population.

2.
Rev Alerg Mex ; 66(2): 263-268, 2019 Apr-Jun.
Artigo em Espanhol | MEDLINE | ID: mdl-31200425

RESUMO

Although there are high quality clinical guidelines about allergic rhinitis, many patients receive deficient treatment, partly due to the high level of self-medication. MASK (Mobile Airways Sentinel Network) is an integral part of a project against chronic diseases which it is focused on active and healthy aging and is supported by the European Union. It forms the third phase of ARIA (Allergic Rhinitis and its Impact on Asthma) in which, through a mobile app on a smart device, the purpose is to guide patients in the control of their multimorbidity, allergic rhinitis or conjunctivitis, or asthma. The "Allergy Diary" app by MACVIA-ARIA is free and it is available for Android and iOS; on it, patients indicate how unpleasant the symptoms are on a daily basis through five screens with an analogous visual scale; two more screens were recently added (sleep affectation). With the app, it is also possible to download the information of the "Allergy Diary" on the physician's computer through a QR code at the moment of the medical consultation. In this article, we review the first year of experience in Spain, Mexico and Argentina, where the Spanish version is used.

3.
Rev Alerg Mex ; 66(1): 140-146, 2019 Jan-Mar.
Artigo em Espanhol | MEDLINE | ID: mdl-31013416

RESUMO

The vast majority of patients with allergic rhinitis (AR) do not receive the proper management which is recommended by the guidelines, but they frequently self-medicate. MASK (Mobile Airways Sentinel Network) is an integral part of a project that is supported by the European Union against chronic diseases and focused on active and healthy aging. MASK represents the third phase of ARIA (Allergic Rhinitis and its Impact on Asthma), in which, by using a mobile application in a smart device, the objective is to guide the patient in the control of his/her multi-morbidity, AR and/or allergic conjunctivitis (AC) and/or asthma. The mobile app Allergy Diary by MACVIA-ARIA is free and it is available for both Android and iOS platforms. After it is downloaded to the patient's cell phone, it first requests some information about the patient's profile, allergic pathologies and medication; afterwards, through a visual analog scale, the patient is invited to determine the degree of affectation in the nose, eyes, and bronchi, and its influence on their productivity at work / school. After analyzing the data generated by filling the Allergy Diary, it became clear there is a new clinical entity: allergic rhinitis+ allergic conjunctivitis +asthma, with greater effect; in addition to a high level of self-medication: in general, the patient takes medication on days when symptoms are present. The app has already been deployed in 23 countries, including several Spanish-speaking countries.

4.
Acta otorrinolaringol. esp ; 70(1): 32-35, ene.-feb. 2019. tab, mapas
Artigo em Inglês | IBECS | ID: ibc-178437

RESUMO

Introduction: Congenital Aural Atresia (CAA) or microtia is a malformation that results in esthetic and functional problems. There is little information on prevalence, considering that Latin American is the most affected region in the world. Objective: To determine the prevalence of microtia, considering the different ethnical structure of the population. Methods: A retrospective analysis was performed of the clinical reports of newborn infants (public hospitals) in three different regions. Results: The incidence of CAA in Argentina was 1 case per 7500 new births (i.e. 1.3/10,000). Marked differences were found per geographical area. The means were calculated per year by bilateral parametric estimation, according to the ethnical origins of the population. In the Caucasoid area: 02.47/10,000 (±1.2), in the Mestizo area: 03.99/10,000 (±0.0) and finally in the Amerindian area: 20.93/10,000 (±0.1). Conclusion: This study shows different incidences according to the demographic features of the population from 1.90/10,000 to 20.9/10,000. This data indicates that CAA is associated with a genetic problem (ethnic differences)


Introducción: La atresia aural congénita (AAC) o microtia es una malformación que produce problemas funcionales y estéticos. Existe falta de información de prevalencia en Argentina, teniendo en cuenta además que Latinoamérica es la región más afectada del mundo. Objetivo: Determinar la prevalencia de microtia, teniendo en cuenta la estructura étnica de la población según las regiones. Métodos: Análisis retrospectivo de historias clínicas en hospitales públicos de recién nacidos en diferentes zonas del país. Resultados: La prevalencia de atresia en Argentina fue de uno de cada 7.500 recién nacidos (1,3/10.000). Se encontraron marcadas diferencias de acuerdo al área geográfica. En el área caucásica: 2,47/10.000 (± 1,2), en el área mestiza: 3,99/10.000 (± 0) y en el área amerindia: 20,93/10.000 (± 0,1). Conclusión: El estudio muestra una diferente incidencia con arreglo a las características demográficas de la población, de entre 1,90/10.000 y 20,9/10.000. Estos datos permitirían asociar la atresia con problemas genéticos (origen étnico)


Assuntos
Humanos , Recém-Nascido , Anormalidades Congênitas/diagnóstico , Orelha/anormalidades , Microtia Congênita/epidemiologia , Argentina/epidemiologia , Estudos Retrospectivos , Hospitais Públicos
5.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-29571523

RESUMO

INTRODUCTION: Congenital Aural Atresia (CAA) or microtia is a malformation that results in esthetic and functional problems. There is little information on prevalence, considering that Latin American is the most affected region in the world. OBJECTIVE: To determine the prevalence of microtia, considering the different ethnical structure of the population. METHODS: A retrospective analysis was performed of the clinical reports of newborn infants (public hospitals) in three different regions. RESULTS: The incidence of CAA in Argentina was 1 case per 7500 new births (i.e. 1.3/10,000). Marked differences were found per geographical area. The means were calculated per year by bilateral parametric estimation, according to the ethnical origins of the population. In the Caucasoid area: 02.47/10,000 (±1.2), in the Mestizo area: 03.99/10,000 (±0.0) and finally in the Amerindian area: 20.93/10,000 (±0.1). CONCLUSION: This study shows different incidences according to the demographic features of the population from 1.90/10,000 to 20.9/10,000. This data indicates that CAA is associated with a genetic problem (ethnic differences).

6.
Cochlear Implants Int ; 19(1): 1-13, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-29073844

RESUMO

OBJECTIVES: To provide multidisciplinary cochlear implant teams with a current consensus statement to support hearing preservation cochlear implantation (HPCI) in children, including those children with symptomatic partial deafness (PD) where the intention is to use electric-acoustic stimulation (EAS). The main objectives are to provide guidelines on who is a candidate, how to assess these children and when to implant if Med-El Flex electrode arrays are chosen for implantation. METHODS: The HEARRING group reviewed the current evidence and practice regarding the management of children to be considered for HPCI surgery emphasizing the assessment needed prior to implantation in order to demonstrate the benefits in these children over time. The consensus statement addresses following three key questions: (1) Should these children be treated? (2) How to identify these children? (3) How to manage these children? SUMMARY: The HEARRING group concludes that irrespective of the degree of residual hearing present, the concepts of hearing and structure preservation should be applied in every child undergoing cochlear implantation and that HPCI is a safe and reliable treatment option. Early detection and multidisciplinary assessment are key to the identification of children with symptomatic PD, these children should undergo HPCI as early as possible.


Assuntos
Implante Coclear/normas , Implantes Cocleares/normas , Correção de Deficiência Auditiva/normas , Perda Auditiva/reabilitação , Estimulação Acústica/métodos , Criança , Pré-Escolar , Consenso , Correção de Deficiência Auditiva/métodos , Estimulação Elétrica/métodos , Feminino , Humanos , Masculino
7.
Artigo em Espanhol | LILACS | ID: biblio-1000286

RESUMO

INTRODUCCIÓN: La enfermedad aislada del seno esfenoidal es rara y representa el 1-2% de todas las patologías inflamatorias sinusales y < 0,05% de las lesiones malignas sinusales. Es difícil establecer el diagnóstico debido a la presentación clínica inespecífica. La cefalea frontal y/o retroocular es la principal manifestación. El retraso en el diagnóstico y tratamiento puede resultar en serias complicaciones debido a sus relaciones anatómicas. OBJETIVOS: Presentar nuestra experiencia en lesiones esfenoidales aisladas, analizando sintomatología, etiología, diagnóstico y tratamiento de las mismas...


INTRODUCTION: Isolated sphenoid sinus disease is rare and accounts for1-2% of all inflammatory sinus pathologies and <0.05% of malignant sinus lesions. It is difficult to establish the diagnosis due to its nonspecific clinical presentation. Frontal and/or retro-ocular headache is the main symptom. Delay in diagnosis and treatment can result in major complications due to their anatomical relationships. OBJECTIVE: Present our experience in isolated sphenoid injuries, through the analysis of symptomatology, etiology, diagnosis and treatment of them...


INTRODUÇÃO: a doença isolada do seio esfenoidal é rara e representa entre 1% e 2% de todas as patologias inflamatórias sinusais e menos de 0,05% das lesões malignas sinusais. É difícil estabelecer o diagnóstico devido a apresentação clínica inespecífica. A cefaleia frontal e/ou retro-ocular é a principal manifestação. O atraso no diagnóstico e no tratamento pode causar complicações sérias devido à suas relações anatômicas. OBJETIVOS: Apresentar nossa experiência em lesões esfenoidais isoladas, analisando a sintomatologia, etiologia, diagnostico e o tratamento...


Assuntos
Humanos , Masculino , Adolescente , Adulto , Seio Esfenoidal , Seio Esfenoidal/cirurgia , Seio Esfenoidal/patologia , Doenças dos Seios Paranasais/etiologia , Sinais e Sintomas
8.
Artigo em Espanhol | LILACS | ID: biblio-1000374

RESUMO

INTRODUCCIÓN: La hipoacusia neurosensorial súbita idiopática se define como la pérdida de audición súbita, de más de 30 dB, en por lo menos 3 frecuencias contiguas de la audiometría tonal, que ocurre dentro de los 3 días de inicio del síntoma, en un paciente sin antecedentes otológicos previos. OBJETIVOS: Evaluar la relación entre el comienzo temprano del tratamiento con corticoide intratimpánico y el grado de recuperación auditiva. MATERIAL Y MÉTODO: Es un estudio observacional, descriptivo y retrospectivo. A través de una revisión de historias clínicas se recolectaron pacientes con diagnóstico de hipoacusia neurosensorial súbita, valorados entre 2016 y 2017. El protocolo terapéutico utilizado fue la inyección de corticoide intratimpánico bajo visión microscópica, del oído afectado. Este procedimiento se realizó una vez por semana, durante 4 semanas. Se solicitó un control audiométrico una vez finalizado el tratamiento para evaluar el grado de recuperación auditiva...


INTRODUCTION: Sudden sensorineural hearing loss surdez neurosensorial subita is defined as a sudden loss of hearing, of more than 30dB, in at least three adjacent frequencies of the tone audiometry, which occurs within the three days after the symptom onset, in patients without previous otologic background. OBJECTIVE: Analyze the relationship between the early beginning of treatment with intratympanic corticoid and the degree of hearing recovery. MATERIAL AND METHOD: This is an observational, descriptive and retrospective study. Medical records of patients with sudden sensorineural hearing loss diagnosis between 2016 and 2017 were gathered. The therapeutic protocol used was injection of intratympanic corticoid in the affected ear under microscopic vision. This procedure was carried out once a week, for 4 weeks. An audiometric control was done after finishing treatment in order to assess the hearing recovery degree…


INTRODUÇÃO: A surdez neurosensorial subita idiopatica define-se como a perda de audição subita, a mais de 30dB, em pelo menos 3 frequências contíguas da audiometria tonal, que ocorre dentro dos 3 dias de início do sintoma, num paciente sem antecedentes otológicos prévios. OBJETIVOS: Avaliar a relação entre o começo temporão do tratamento com corticoide intratimpánico e o grau de recuperação auditiva. MATERIAL E MÉTODO: É um estudo observacional, descritivo e retrospectivo. Através de uma revisão de histórias clínicas colectaram-se pacientes com diagnóstico de hipoacusia neurosensorial súbita, avaliados entre 2016 e 2017. O protocolo terapêutico utilizado foi a injeção de corticoide intratimpánico baixo visão microscópica, do ouvido afectado. Este procedimento realizou-se uma vez por semana, durante 4 semanas. Solicitou-se um controle audiométrico uma vez finalizado o tratamento para avaliar o grau de recuperação auditiva...


Assuntos
Humanos , Masculino , Adulto , Dexametasona/administração & dosagem , Dexametasona/uso terapêutico , Perda Auditiva Neurossensorial/tratamento farmacológico , Perda Auditiva Neurossensorial/reabilitação , Correção de Deficiência Auditiva/estatística & dados numéricos , Estudos Retrospectivos , Corticosteroides , Intervenção Médica Precoce/estatística & dados numéricos , Estudo Observacional
9.
Rev. Fed. Argent. Soc. Otorrinolaringol ; 25(1): 32-36, 2018. graf, ilus
Artigo em Espanhol | LILACS | ID: biblio-1005303

RESUMO

INTRODUCCIÓN: La enfermedad de Ménière es una vestibulopatía frecuente que se manifiesta con crisis de vértigo, acúfenos, plenitud aural y pérdida auditiva neurosensorial. La hipoacusia es un síntoma fundamental para realizar el diagnóstico y se puede presentar de diversas formas. OBJETIVO: Describir las morfologías de las curvas audiométricas de los pacientes con enfermedad de Méniére al momento del diagnóstico. MATERIAL Y MÉTODOS: Estudio retrospectivo. Se evaluaron 99 pacientes. Se les realizaron estudios audiométricos y se registró el umbral tonal medio, el estadio correspondiente, la presencia de hipoacusia conductiva y la morfología de la curva audiométrica...


INTRODUCTION: Ménière disease is a frequent vestibular desorder that causes vertigo attacks, tinnitus, aural fullness and sensorineural hearing loss. Hearing loss is an essential symptom to get certain diagnosis and it can appear in several shapes. OBJECTIVE: to describe the configurations of the audiometric curves of patients with Ménière desease at the first visit. MATERIAL AND METHODS: A retrospective study included 99 patients. Audiometric studies were performed and mean tonal thresholds, corresponding stage, conductive hearing loss and audiometric curve configurations were recorded…


INTRODUÇÃO: A doença de Ménière é uma vestibulopatia freqüente que se manifesta com crise de vertigem, zumbido, plenitude aural e perda auditiva neurossensorial. A perda de audição é um sintoma fundamental para fazer o diagnóstico mais pode se apresentar com muitas formas. OBJETIVO: Descrever as morfologias das curvas audiométricas em pacientes com doença de Méniére no momento do diagnóstico. MATERIAL E MÉTODOS: Estudo retrospectivo. 99 pacientes foram avaliados. Estudos audiológicos foram feitos e o limiar tonal meia, o estágio, a presença de perda auditiva condutiva e o desenho da curva audiométrica foram analisados...


Assuntos
Humanos , Masculino , Adolescente , Adulto , Audiometria/estatística & dados numéricos , Doença de Meniere/diagnóstico , Audiometria/métodos , Estudos Retrospectivos
10.
World Allergy Organ J ; 10(1): 37, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29158869

RESUMO

Otitis Media with Effusion (OME) is an inflammatory condition of the middle ear cleft, acute or chronic, with collection of fluid in the middle ear with an intact tympanic membrane. It is a very common disease in childhood, the most frequent cause of hearing loss in childhood and often requiring surgery. OME is called chronic when the fluid in the middle ear persists for more than three months or when the episodes recur six or more times in one year. The current article covers various aspects of OME including definition, epidemiology. Pathomechanisms, risk factors, role of allergy in OME, impact of upper airway disease on OME, eosinophilic otitis media and management of OME.

11.
Rev Alerg Mex ; 64(3): 298-308, 2017 Jul-Sep.
Artigo em Espanhol | MEDLINE | ID: mdl-29046028

RESUMO

The ARIA initiative was started during a World Health Organization workshop in 1999. The initial goals were to propose a new classification for allergic rhinitis, to promote the concept of multi-morbidity in asthma and rhinitis and to develop guidelines with stakeholders for world-wide use. ARIA is now focused on the implementation of emerging technologies for individualized and predictive medicine. MASK: MACVIA-Aria Sentinel Network uses mobile technology to develop care pathways that enable management by a multidisciplinary group or by patients themselves. An App for iOS and Android uses a visual analogue scale to assess symptom control and work productivity, as well as a clinical decision support system; it is associated with an interoperable tablet for health professionals. The escalation strategy uses recommendations of the European Innovation Partnership on Active and Healthy Ageing. The aim of ARIA's new approach is to provide an active and healthy life to people affected by rhinitis, regardless of age, gender or socioeconomic status, in order to reduce social and health inequalities caused by the disease.

12.
Acta Otolaryngol ; 136(6): 556-8, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26981711

RESUMO

Conclusion Bonebridge (BB) and Sophono (SP) devices improved hearing; with the BB implant showing a better performance at medium and high frequencies. Furthermore, the BB, as an active implant, showed higher functional gain and increased time of use, when compared to the SP, a passive system. Objectives This study aims to compare surgical and audiological outcomes of SP and BB devices in order to assess and further differentiate the indication criteria. Methods Fourteen patients with conductive and mixed hearing loss were evaluated pre- and post-operatively (BB or SP) (period 2013-2014). Age, gender, surgical history, cause and type of hearing loss, implant use per day, levels of bone and air conduction, and functional gain were recorded. Data was analysed by Wilcoxon singed-rank and Wilcoxon rank-sum tests. Results Fourteen patients (BB; n = 10 and SP; n = 4) with an average age = 25.42 years (CI95 = 12.41-38.43) were evaluated. The gender relation was equal (1:1), with pre-implantation osseous thresholds of 20.42 dB (CI95 = 11.15-29.69), and pre-implantation aerial thresholds of 70.83 dB (CI95 = 62.52-79.14). The SP wearing time was significantly lower than that of the BB (SP = 7-10 h/day, BB = 8-12 h/day; p = 0.0323). The functional gain did not differ significantly between the two devices (BB = 40.00 ± 13.19 dB, SP = 34.06 ± 15.63 dB; p = 0.3434), but a significant improvement from pre- to post-implantation was observed (p < 0.05). BB and SP decreased auditory thresholds at 1 and 2 kHz (< 0.01), respectively. The BB even significantly decreased thresholds at 0.5 kHz (p = 0.0140) and 4 kHz (p < 0.0001). No relevant surgical complications were found.


Assuntos
Condução Óssea , Auxiliares de Audição , Procedimentos Cirúrgicos Otológicos , Implantação de Prótese , Adolescente , Adulto , Criança , Feminino , Humanos , Masculino , Adulto Jovem
13.
Eur Arch Otorhinolaryngol ; 273(12): 4103-4110, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26968179

RESUMO

The objective of the study was to evaluate postoperative pain following a transcutaneous active conductive hearing implant. 27 patients undergoing Bonebridge (BB) bone conduction implantation were evaluated with two pain-related questionnaires. The Headache Impact Test (HIT-6) was used to measure the degree of disability including none or little impact (≤49), mild (50-55), moderate (56-59), and severe (≥60). The Brief Pain Inventory (BPI) was used to assess pain severity score and function interference (0 = no pain to 10 = worst pain); meaningful pain was considered to be ≥3. The impact of surgical factors on postoperative pain was analyzed. Postoperative BB pain results were compared with 11 Vibrant Soundbridge™ (VSB) and 103 cochlear implant (CI) users. The mean pre- and postoperative HIT-6 scores for BB implantation were 42.6 and 41.8, respectively and the mean preoperative BPI pain severity score changed from 0.6 to 0.9 postoperatively, whereas the preoperative interference score changed from 0.1 to 0.3. None of the mean postoperative values revealed significant pain. The retrosigmoid approach, the need for dural or sinus compression, and the use of bone conduction implant lifts had no significant impact on pain scores. The mean postoperative HIT-6 pain scores for patients with BB, VSB, and CI were 41.8, 46.4, and 42.8, respectively, with the differences not being significant. BB implantation causes no significant postoperative pain irrespective of sinus or dura compression. Pain scores were similar to those experienced by patients with other transcutaneous auditory implants such as middle ear or CIs.


Assuntos
Condução Óssea , Auxiliares de Audição , Medição da Dor , Dor Pós-Operatória/etiologia , Próteses e Implantes , Adulto , Estudos de Coortes , Feminino , Humanos , Masculino
14.
Rev. argent. neurocir ; 30(1): 23-26, mar. 2016. ilus, tab
Artigo em Espanhol | LILACS | ID: biblio-835752

RESUMO

Objetivo: Presentar nuestra experiencia en el tratamiento de meningiomas del ángulo pontocerebeloso, desde 1972 a 2013. Material y Método: Se realizó un trabajo retrospectivo y descriptivo. Se incluyeron 8 casos de pacientes con meningiomas de ángulo pontocerebeloso, cuyas edades oscilaron entre 41 y 68 años; 7 de ellos fueron mujeres. Resultados: Se realizaron 8 cirugías de exéresis tumoral. En un paciente se realizó, además, radioterapia por presentar recurrencia. En 5 casos la resección fue total (Simpson 1 o 2) y en 3 fue parcial. Los primeros se localizaban todos a nivel posterior del complejo VII-VIII. Hubo un caso de muerte postquirúrgica por sepsis secundaria a un absceso de la cavidad operatoria. Conclusión: En los meningiomas de ángulo pontocerebeloso, principalmente en aquellos ubicados por detrás del conducto auditivo interno, la exéresis completa es posible y constituye un tratamiento capaz de controlar la enfermedad. La radioterapia sería una opción a considerar en un número limitado de enfermos.


Objective: To present our experience in the treatment of cerebellopontine angle (CPA) meningiomas from 1972 to 2013. Materials and Methods: A descriptive, retrospective study was performed involving eight patients (7 females) with a cerebellopontine angle meningioma, whose ages ranged from 41 to 68 years. Results: Tumor resection was performed in all eight patients, with one patient requiring subsequent radiotherapy for tumor recurrence. In five patients, resection was complete (Simpson 1 or 2), while only partial resection was achieved in three. The former lesions were all posterior to the VII-VIII complex. There was one death from post-surgical sepsis secondary to an abscess in the surgical cavity. Conclusions: With meningiomas of the CPA, and especially those located behind the internal auditory canal, complete excision is possible and treatment can control the disease. Radiotherapy is an option to consider in a limited number of patients.


Assuntos
Humanos , Cirurgia Geral , Meningioma , Radioterapia
15.
Audiol Neurootol ; 21(6): 391-398, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-28319951

RESUMO

BACKGROUND: While hearing aids for a contralateral routing of signals (CROS-HA) and bone conduction devices have been the traditional treatment for single-sided deafness (SSD) and asymmetric hearing loss (AHL), in recent years, cochlear implants (CIs) have increasingly become a viable treatment choice, particularly in countries where regulatory approval and reimbursement schemes are in place. Part of the reason for this shift is that the CI is the only device capable of restoring bilateral input to the auditory system and hence of possibly reinstating binaural hearing. Although several studies have independently shown that the CI is a safe and effective treatment for SSD and AHL, clinical outcome measures in those studies and across CI centers vary greatly. Only with a consistent use of defined and agreed-upon outcome measures across centers can high-level evidence be generated to assess the safety and efficacy of CIs and alternative treatments in recipients with SSD and AHL. METHODS: This paper presents a comparative study design and minimum outcome measures for the assessment of current treatment options in patients with SSD/AHL. The protocol was developed, discussed, and eventually agreed upon by expert panels that convened at the 2015 APSCI conference in Beijing, China, and at the CI 2016 conference in Toronto, Canada. RESULTS: A longitudinal study design comparing CROS-HA, BCD, and CI treatments is proposed. The recommended outcome measures include (1) speech in noise testing, using the same set of 3 spatial configurations to compare binaural benefits such as summation, squelch, and head shadow across devices; (2) localization testing, using stimuli that rove in both level and spectral content; (3) questionnaires to collect quality of life measures and the frequency of device use; and (4) questionnaires for assessing the impact of tinnitus before and after treatment, if applicable. CONCLUSION: A protocol for the assessment of treatment options and outcomes in recipients with SSD and AHL is presented. The proposed set of minimum outcome measures aims at harmonizing assessment methods across centers and thus at generating a growing body of high-level evidence for those treatment options.


Assuntos
Implante Coclear/métodos , Consenso , Surdez/reabilitação , Auxiliares de Audição , Perda Auditiva Unilateral/reabilitação , Percepção da Fala , Implantes Cocleares , Surdez/fisiopatologia , Perda Auditiva Unilateral/fisiopatologia , Humanos , Estudos Longitudinais , Ruído , Estudos Prospectivos , Qualidade de Vida , Localização de Som , Inquéritos e Questionários , Zumbido , Resultado do Tratamento
16.
Int. arch. otorhinolaryngol. (Impr.) ; 19(4): 343-348, Oct.-Dec. 2015. tab, graf, ilus
Artigo em Inglês | LILACS | ID: lil-768338

RESUMO

Introduction Bone conduction implants are indicated for patients with conductive and mixed hearing loss, as well as for patients with single-sided deafness (SSD). The transcutaneous technology avoids several complications of the percutaneous bone conduction implants including skin reaction, skin growth over the abutment, and wound infection. The Bonebridge (MED-EL, Austria) prosthesis is a semi-implantable hearing system: the BCI (Bone Conduction Implant) is the implantable part that contains the Bone Conduction-Floating Mass Transducer (BC-FMT), which applies the vibrations directly to the bone; the external component is the audio processor Amadé BB (MED-EL, Austria), which digitally processes the sound and sends the information through the coil to the internal part. Bonebridge may be implanted through three different approaches: the transmastoid, the retrosigmoid, or the middle fossa approach. Objective This systematic review aims to describe the world́ s first active bone conduction implant system, Bonebridge, as well as describe the surgical techniques in the three possible approaches, showing results from implant centers in the world in terms of functional gain, speech reception thresholds and word recognition scores. Data Synthesis The authors searched the MEDLINE database using the key term Bonebridge. They selected only five publications to include in this systematic review. The review analyzes 20 patients that received Bonebridge implants with different approaches and pathologies. Conclusion Bonebridge is a solution for patients with conductive/mixed hearing loss and SSD with different surgical approaches, depending on their anatomy. The system imparts fewer complications than percutaneous bone conduction implants and shows proven benefits in speech discrimination and functional gain.(AU)


Assuntos
Condução Óssea/fisiologia , Perda Auditiva Condutiva , Implantes Cocleares , Timpanoplastia
17.
Int Arch Otorhinolaryngol ; 19(4): 343-8, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26491482

RESUMO

Introduction Bone conduction implants are indicated for patients with conductive and mixed hearing loss, as well as for patients with single-sided deafness (SSD). The transcutaneous technology avoids several complications of the percutaneous bone conduction implants including skin reaction, skin growth over the abutment, and wound infection. The Bonebridge (MED-EL, Austria) prosthesis is a semi-implantable hearing system: the BCI (Bone Conduction Implant) is the implantable part that contains the Bone Conduction-Floating Mass Transducer (BC-FMT), which applies the vibrations directly to the bone; the external component is the audio processor Amadé BB (MED-EL, Austria), which digitally processes the sound and sends the information through the coil to the internal part. Bonebridge may be implanted through three different approaches: the transmastoid, the retrosigmoid, or the middle fossa approach. Objective This systematic review aims to describe the world́s first active bone conduction implant system, Bonebridge, as well as describe the surgical techniques in the three possible approaches, showing results from implant centers in the world in terms of functional gain, speech reception thresholds and word recognition scores. Data Synthesis The authors searched the MEDLINE database using the key term Bonebridge. They selected only five publications to include in this systematic review. The review analyzes 20 patients that received Bonebridge implants with different approaches and pathologies. Conclusion Bonebridge is a solution for patients with conductive/mixed hearing loss and SSD with different surgical approaches, depending on their anatomy. The system imparts fewer complications than percutaneous bone conduction implants and shows proven benefits in speech discrimination and functional gain.

18.
Acta Otolaryngol ; 135(12): 1277-85, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26223816

RESUMO

CONCLUSION: Bone conduction implants are useful in patients with conductive and mixed hearing loss for whom conventional surgery or hearing aids are no longer an option. They may also be used in patients affected by single-sided deafness. OBJECTIVES: To establish a consensus on the quality standards required for centers willing to create a bone conduction implant program. METHOD: To ensure a consistently high level of service and to provide patients with the best possible solution the members of the HEARRING network have established a set of quality standards for bone conduction implants. These standards constitute a realistic minimum attainable by all implant clinics and should be employed alongside current best practice guidelines. RESULTS: Fifteen items are thoroughly analyzed. They include team structure, accommodation and clinical facilities, selection criteria, evaluation process, complete preoperative and surgical information, postoperative fitting and assessment, follow-up, device failure, clinical management, transfer of care and patient complaints.


Assuntos
Condução Óssea/fisiologia , Consenso , Perda Auditiva Condutiva-Neurossensorial Mista/cirurgia , Próteses e Implantes/normas , Ajuste de Prótese/métodos , Percepção da Fala/fisiologia , Seguimentos , Perda Auditiva Condutiva-Neurossensorial Mista/fisiopatologia , Humanos , Desenho de Prótese , Fatores de Tempo
19.
World Allergy Organ J ; 8(1): 10, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25977744

RESUMO

Epidemiologic studies suggest that the prevalence of allergic rhinitis (AR) is rising worldwide. Several reports, in fact, indicate increasing trends in the prevalence of AR especially in developing countries, likely related to the environment and climate changes and the adoption of an urbanized Western lifestyle. The primary objective of the present study was to collect information about management in real-life settings, including a characterization of typical patients' profile referring to physicians, the disease features, the common approaches to diagnostic assessments and therapeutic decisions. This was an international, multicenter, cross-sectional study conducted in adults or children (≥6 years) suffering from rhinitis confirmed by physician's diagnosis for at least one year. The 234 physicians who participated in the study included a total of 2778 patients in Egypt, Mexico, Brazil, Colombia, Guatemala, Iran, Venezuela, Argentina, Israel, Kuwait and United Arab Emirates. It was found that clinical history was the selected tool to diagnose and categorize AR patients (97.1%), with less than half of patients undergoing allergy testing, may be explaining the scarce use of immunotherapy on management of disease. Out of 2776 patients, 93.4% had somehow received a recommendation to avoid allergens and irritant agent exposure. Notably, 91.4% were receiving at least one treatment at the time of the survey, mostly oral antihistamines (79.7%) and intranasal corticosteroids (66.3%). Oral antihistamines, intranasal steroids and decongestants were considered both safe and effective by patients and physicians, preferring oral and nasal route of administration. The ISMAR registry was designed according to the most accepted epidemiological recommendations, and provides interesting information regarding the management of rhinitis from a patient and physician points of view, with many similarities between the participating countries. Further efforts are required to better manage AR and its comorbidities.

20.
Braz. j. otorhinolaryngol. (Impr.) ; 81(2): 190-196, Mar-Apr/2015. tab, graf
Artigo em Inglês | LILACS | ID: lil-745806

RESUMO

INTRODUCTION: Electroacoustic stimulation is an excellent option for people with residual hearing in the low frequencies, who obtain insufficient benefit with hearing aids. To be effective, the subject's residual hearing should be preserved during cochlear implant surgery. OBJECTIVES: To evaluate the hearing preservation in patients that underwent implant placement and to compare the results in accordance with the approach to the inner ear. METHODS: 19 subjects underwent a soft surgical technique, and the electrode MED-EL FLEX(tm) EAS, designed to be atraumatic, was used. We evaluated pre- and postoperative tonal audiometric tests with an average of 18.4 months after implantation, to measure the rate of hearing preservation. RESULTS: 17 patients had total or partial preservation of residual hearing; 5 had total hearing preservation and two individuals had no preservation of hearing. The insertion of the electrode occurred through a cochleostomy in 3 patients, and in 2 of these there was no hearing preservation; the other 16 patients experienced electrode insertion through a round window approach. All patients benefited from the cochlear implant, even those who are only using electrical stimulation. CONCLUSION: The hearing preservation occurred in 89.4% of cases. There was no significant difference between the forms of inner ear approach. .


INTRODUÇÃO: A estimulação eletroacústica é uma excelente opção para pessoas com audição residual nas baixas frequências, que obtêm benefício insuficiente com aparelhos auditivos. Para ser eficaz, a audição residual deve ser preservada durante a cirurgia de implante coclear. OBJETIVOS: Avaliar a preservação auditiva de pacientes implantados e comparar os resultados de acordo com a abordagem da orelha interna. MÉTODO: 19 indivíduos foram implantados com uma técnica cirúrgica para preservação auditiva, tendo sido utilizado o eletrodo MED-EL FLEXTM EAS, concebido para ser atraumático. Foram avaliados os exames audiométricos tonais no pré e pós-operatório, com uma média de 18,4 meses após o implante para medir a taxa de preservação da audição residual. RESULTADOS: 17 pacientes tiveram preservação total ou parcial da audição residual; cinco obtiveram preservação da audição total e dois indivíduos não tiveram preservação da audição. A inserção do eletrodo ocorreu por cocleostomia em 3 pacientes; em 2 destes pacientes não houve preservação da audição. Os outros 16 pacientes foram submetidos à abordagem pela janela redonda. Todos os pacientes foram beneficiados com o implante coclear, mesmo aqueles pacientes que utilizando apenas estimulação elétrica. CONCLUSÃO: A preservação auditiva ocorreu em 89,4% dos casos. Não houve diferença significativa entre as formas de abordagem da orelha interna. .


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Adulto Jovem , Implante Coclear/métodos , Implantes Cocleares , Perda Auditiva Unilateral/diagnóstico , Perda Auditiva Unilateral/cirurgia , Limiar Auditivo , Estimulação Elétrica , Testes Auditivos , Período Pós-Operatório , Estudos Prospectivos , Ajuste de Prótese , Janela da Cóclea/cirurgia , Percepção da Fala , Membrana Timpânica/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA